Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Phase I/II trial evaluates KW-2871 combination therapy in melanoma

June 14, 2012

Data from expanded moxetumomab trial support further testing

June 14, 2012

Phase I and II trials assess Gradalis cancer vaccines

June 12, 2012

Phase I study evaluates peptide vaccine including cancer/testis antigens

June 6, 2012

OMP-59R5 well tolerated in phase I study

June 6, 2012

OTSA-101 receives E.U. orphan drug status

June 5, 2012

Treatment begins in study of Genelux's vaccinia-based oncolytic viral therapy

June 1, 2012

City of Hope obtains grant to develop T-cell treatment targeting brain tumor cells

May 31, 2012

Cytotoxic T lymphocytes expressing Epstein-Barr virus antigen administered to patients with lymphoma

May 30, 2012

Morphotek produces novel monoclonal antibodies for cancer

May 25, 2012

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...